SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061560
Filing Date
2023-11-09
Accepted
2023-11-09 08:22:36
Documents
47
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q labp-20230930.htm   iXBRL 10-Q 1465908
2 EX-31.1 labp-ex31_1.htm EX-31.1 24251
3 EX-32.1 labp-ex32_1.htm EX-32.1 14629
  Complete submission text file 0000950170-23-061560.txt   5486611

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT labp-20230930.xsd EX-101.SCH 36016
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT labp-20230930_cal.xml EX-101.CAL 29704
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT labp-20230930_lab.xml EX-101.LAB 343804
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT labp-20230930_pre.xml EX-101.PRE 246009
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT labp-20230930_def.xml EX-101.DEF 143171
41 EXTRACTED XBRL INSTANCE DOCUMENT labp-20230930_htm.xml XML 844728
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39971 | Film No.: 231390195
SIC: 2834 Pharmaceutical Preparations